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An energy-dispersive X-ray fluorescence system (EDXRF) was optimized for simultaneous detection 
of gold and silver nanoparticles inside water-equivalent phantoms applied to theranostics. The 
optimization process was carried out in order to maxi ize the fluorescence detection, keeping dose 
levels as low as possible. Gold and silver fluorescent emissions were simultaneously detected 
emerging from phantom’s volume, allowing the future d velopment of multi-parametric imaging 
associated to specific tumor characteristics. For fluorescence detection, gold LIII -edge and silver K-
edge emission lines were used, exited with a conventional X-ray source with a tungsten target. Several 
combinations of filters of different thickness were used to hardening the Bremsstrahlung spectrum, 
thus producing energetically narrow beams with central energy according to both excitation edges. In 
the case of gold, incident spectrum was optimized by means of strontium (Sr) and yttrium (Y) filters to 
relatively incrementing photons capable of exciting gold LIII -edge, while silver K-edge excitation was 
improved using a tin (Sn) filter.  Filtering combinations made of 212.0 µm Sr with 94.5 µm Sn, and 
130.2 µm Y with 94.5 µm Sn maximized fluorescence detection sensitivity and minimized delivered 
dose, resulting in doses 2.24 and 2.36 times lower than individual gold or silver fluorescent detection. 
Furthermore, when dual gold and silver fluorescent detection was performed, the minimum detectable 
concentration was lower than single element detection: 0.042±0.002 mg/mL of Au and 0.024±0.005 
mg/mL of Ag in dual detection against 0.058±0.003 mg/ L of Au and 0.124±0.007 mg/mL of Ag 
when measured independently. 
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Currently, the infusion of high atomic number nanoparticle agents within biological tissue, represents 
one of the most promising technologies aimed at imag ng and therapeutic medical tasks. Among its 
potentialities, it would offer: tumor markers (Hainfeld et al., 2006; Cheong et al., 2010), real-time 
monitoring (Manohar et al., 2013; Ricketts et al., 2013; Santibáñez et al., 2017; Wu et al., 2013) and 
dose enhancement highly localized (Delorme et al., 2017; Hainfeld et al., 2013, 2004; Mattea et al., 
2017; Ngwa et al., 2014; Santibáñez et al., 2018; Zhang et al., 2014).  
Gold and silver nanoparticles (GNPs and AgNPs) have be n studied in detail and 
functionalized bounding to lipids (Bromma et al., 2019; Yang et al., 2018), peptides (Albertini et al.,
2019; Chen et al., 2016; Grüner et al., 2018) and proteins (Liu and Peng, 2017; Wangoo et al., 2008), 
increasing their internalization and biocompatibility, as well as bounding to antibodies linked to 
specific cell receptors that have an overexpression in tumor cells (Popovter et al, 2011; Hainfeld et al, 
2011), allowing to incorporate in a higher concentration inside malignant cells versus healthy tissue 
cells (Ahn et al., 2013; Hainfeld et al., 2013, 2006).  
These improvement achieved in the generation of high specificity biomolecules decorated-
nanoparticles, have motivated nanoparticles future use for small clusters of cancer cells detection  (not
allowed by traditional contrast image agents) or to pr vide tumor characteristics information like 
distribution and radiosensitivity of the tumor cells (by supplying simultaneously different 
nanoparticles decorated with biomarkers associated with each tumor characteristics) allowing to 
generate multiparametric images and produce personalized cancer therapy regimes (Ricketts et al., 
2012). 
Different X-ray techniques has been proposed to ident fy and quantify high Z nanoparticles 
allowing different detection limits and sensibility. The most studied techniques were conventional 
computed tomography (CT) and micro-CT systems (Hainfeld et al., 2011, 2010; Popovtzer et al., 
2008). However, CT and micro-CT techniques do not all w simultaneous distinction among different 
types of nanoparticles embedded in the tumor. Energy Dispersive X-ray Fluorescence (EDXRF) is an 
effective, fast and non-destructive multielemental technique to determine trace elements in different 
types of samples offering advantages compared to devices based only on the incident beam 
attenuation. Several experimental setups have been evaluated for quantification of gold and silver 
nanoparticles by bench-top EDXRF systems, using both L and K lines for the detection, thus 
achieving different sensitivity ranges and depths (Figueroa et al., 2015; Manohar et al., 2013; Ren et 
al., 2014; Ricketts et al., 2016, 2013, 2012; Santibáñez et al., 2017; Wu et al., 2013). EDXRF studies 
enabled multiparametric imaging of each nanoparticle and the possibility of correlating the biomarker 
















One of the common challenges faced, when using these n w agents, is the need to develop 
detection methodologies: in vivo, quick, efficient, with greater sensitivity and lower doses in those 
cases involving organisms. Optimizing incident spectrum produced by bench-top EDXRF system that 
efficiently excites nanoparticles of two different elements is an important challenge for implementing 
future clinical analysis of the tumor characteristic of each patient. 
The aim of this work is to characterize an optimized EDXRF system to detect and quantify in 
vivo lower concentration of GNPs and AgNPs distributed in tissue-equivalent phantom, requiring 
lowest surface doses to allow this range of sensitivity. System characterization was carried out testing 
different combinations of filters with different thickness used to hardening the Bremsstrahlung 
spectrum, thus producing energetically narrow beams with central energy closer to excitation edges 
Ag-Kα and Au-LIII, improving the sensitivity-doses relationship and using like statistical figure of 




2.1. Experimental setup 
 
The setup used for gold nanoparticles (GNPs) and silver nanoparticles (AgNPs) detection was 
mounted in the LIIFAMIRX beamline (Valente et al., 2016) at FAMAF (Universidad Nacional de 
Córdoba, Argentina) as depicted in Fig. 1. The essential parts are: 1) A 3 kW Kristallofex X-ray 
generator with tube voltage of 20-60 kV and tube current of 5-50 mA. The tube is equipped with a 
tungsten target and a mylar output window of 50 µm thickness. 2) An Amptek X-100 CdTe �/X-ray 
spectrometer consisting of a cadmium tellurium detector coupled to the DP5 Amptek Digital Pulse 
Processor MCA and power supplies. The active volume of the detector has an area of 9 mm2 and a 
1000 µm thick with a 100 µm beryllium entrance window. The typical resolution f the detector is 
0.530 keV (0.850 keV) full width at half maximum (FWHM) at 14.4 keV (122.0 keV) and the 
maximum count rate up to 2x105 counts per second. 3) A ionization chamber model TN 30013 (PTW, 
Freiburg, Germany) with a sensitive volume of 0.6 cm3 onnected to an electrometer model UNIDOS 
E (PTW, Freiburg, Germany), calibrated by standard l boratory for determining absorbed dose in 
water, exposition and KERMA in air. Dose measurements were carried out with an acrylic cylindrical-
shaped (35 mm diameter and 53 mm height) phantom filled with deionized water, as shown in Fig. 1. 
The phantom was located at 95 cm from the X-ray source exit window, and jaws-like  
collimation system placed at 17 cm from the source was used to configure beam size as well as filters' 
positioning, as depicted in Fig. 1. The detector system was placed  at 2.5 cm from the phantom surface 
aimed at increasing detection solid angle. Phantom alignment was verified using digital radiography 















Fig. 1. With this configuration, the resulting beam spot area was 1.5 cm2, therefore a complete 
illumination of the region of interest was assured. 
  
 
Fig. 1. EDXRF experimental setup for simultaneous gold and silver nanoparticles fluorescence 
detection (top) and picture of the experimental set up for dosimetry measurements (bottom). 
 
2.2. Sample preparation 
 
An equivalent soft-tissue phantom was prepared using 96% w/w cellulose (C6H10O5)n and 4%  w/w of 
sodium chloride (NaCl), as described elsewhere (Santibáñez et al., 2017), both reactants of analytical 
grade purchased from Merck (Germany). The phantom is a cylindrical-shaped (35 mm diameter and 
30 mm height) having a 0.3 cm3 cavity to place a “tumor phantom” doped with different 
concentrations of nanoparticles. The composition of the tumor phantom used to evaluate the different 
settings consisted of a mixture of 7.500 mg/mL of GNPs (1.9 nm diameter purchased from Aurovist, 
Nanoprobes Inc., U.S.) and 7.500 mg/mL of AgNPs (8.2±2.0 nm diameter synthesized according to 















from 0.010 mg/mL to 7.500 mg/mL. Concentration uncertainties were estimated to be less than 12% 
for lower concentrations and around 3% for the higher concentrations. Fig. 2 shows a picture of the 
“tumor phantom” for different nanoparticles concentrations. 
 
 
Fig. 2. Tumor phantoms with different GNPs and AgNPs concentrations ranging from 0.010 to 7.500 
mg/mL. 
 
2.3. Optimized spectrum by suitable filtering and assessment of limit of detection 
 
To assess the optimal incident spectrum for the simultaneous detection of gold and silver nanoparticles 
in tumor phantom, different combinations of filters were used to configure the X-ray beam. The effect 
of including absorption filters made of different elements was to increment the relative quantity of 
photons with energy enough to excite the gold LIII -edge (11.9 keV), such as strontium (Sr) and yttrium 
(Y). Aiming to produce the analogue effect for silver K-edge (25.5 keV), a tin (Sn) was used.  
Absorption filters were purchased from (EXAFS Materials, Danville, CA 94526 USA). 
After beam hardening, the obtained spectra resulted as two energetically narrow beams centered on the 
specific excitation energy slightly above each edge. Fig. 3 shows two spectra optimized in terms of the 
capability of simultaneous excitation of Au LIII  and Ag K lines: “Spectrum A” obtained using 212.0 
µm Sr and 94.5 µm Sn filters, and “Spectrum B” obtained using 130.2 µm Y and 94.5 µm Sn filters. 
For these measurements, all spectra were configured setting current tube at 20 mA and 35 kV voltage 
during 120 s acquisition time. Additionally, measurements were performed using only one filter with 
the aim of further comparisons in terms of sensitivity and absorbed dose for cases of a filtering 
devoted to simultaneous optimization of GNPs (“Spectrum C”)  and AgNPs (“Spectrum D”). The 
information of which filter was used for each spectrum was summarized in Table 1 and measured 
spectra are depicted in Fig. 3. 
The statistical figures of merit used for evaluating the optimal spectrum in terms of increasing 















absorbed dose required for achieving certain level of sensitivity. The LoD was calculated using one of 





      (1) 
 
where IB stands for background counts, IF stand for the fluorescent signal counts and C represents the 
nanoparticles concentration in the sample. Additionally, the LoD values were weighted by a factor that 
equals the resulting dose from using each spectrum to achieve the same LoD, considering that LoD is 
inversely proportional to the square root of the detection time (Santibáñez et al., 2016; Santibáñez et 
al., 2017). 
 
Table 1. Set of filters used for X-ray spectrum modification. 
Detection Spectrum ID Configuration of filters 
Simultaneous 
Spectrum A Sr (212.0 µm) and Sn  (94.5 µm) 
Spectrum B  Y (130.2 µm) and Sn (94.5 µm) 
Single 
Spectrum C Y (130.2 µm) 




Fig. 3. A) Optimized spectra obtained by combining different filters: Spectrum A (blue line) obtained using 212 
µm Sr with 94.5 µm Sn filters and  Spectrum B (black line) obtained using 130.2 µm Y with 94.5 µm Sn. B) 
Single element XRF detection: Spectrum C obtained with 130.2 µm Y filter (red line) and Spectrum D obtained 
with 94.5 µm Sn filter (black line). 
 
The evaluation of the LoD for simultaneous detection was carried out by corresponding 
response curves of the fluorescent signal as a function of the concentration for each nanoparticle type. 
Acquisition time was fixed to deliver 0.250 mGy to the phantom considering concentrations of each 















achieved by the configurations for individual samples consisting of pure Au or Ag nanoparticles were 
evaluated for further comparison purposes. 
On the other hand, evaluation of absorbed dose corrsponding to a fixed LoD of 0.100 mg/mL 
for samples made of GNPs and AgNPs. The improvement in the dose necessary for obtain a fixed 
sensitivity, using as figure of merits the feasibility of obtaining a LoD of 0.100 mg/mL of gold and 
silver nanoparticles in a sample prepared with a concentration of 5.000 mg/mL of Au and Ag 
nanoparticles (correspond to a signal-to-noise ratio of 150 in an exploratory examination), was 
evaluated using spectra depicted in Table 1.  
The evaluation of the LoD of the simultaneous detection was carried out by calibration curves 
of the fluorescent signal as a function of the concentration of each nanoparticle type. Fluorescent 
signal intensity was calculated by background subtraction of the corresponding spectrum of the tumor 
phantom filled with deionized water. Acquisition time was fixed to deliver 0.250 mGy to the phantom 
considering concentrations of each nanoparticle typ for the tumor phantom ranging from 0.010 to 
7.500 mg/mL. Additionally, the detection limit achieved by the configurations for single element 
measurement of Au and Ag nanoparticles, were evaluated for further comparison purposes. 
 
 
3. Results and discussions 
 
All filtering configurations were measured to determine which one has the highest sensitivity 
at the lowest radiation dose for simultaneous detection of silver K alpha and gold L alpha fluorescent 
emissions. The configurations for simultaneous gold an  silver fluorescence detection lead to similar 
results but Spectrum B conduce to higher sensitivity in gold fluorescence detection. Obtained LoD 
values, weighted LoD and absorbed dose are reported in Table 2 along with the obtained results for 
each individual filter. As can be observed, weighted LoD are 2% (5%) of the individual detection of 
gold (silver) fluorescence for Spectrum A and 5% (5%) of the individual detection of gold (silver) 
fluorescence for Spectrum B, indicating a significant improvement in minimum detectable 
concentrations and lower dose levels.  
The similarity in the results obtained for the detection of silver nanoparticles, versus the clear 
difference achieved by one of the configurations in the detection of gold nanoparticles, can be 
explained by observing the incident spectrum in both configurations in Fig. 3. For the spectral region 
associated with the excitation of gold L line, it is observed that the closest proximity of the K-
absorption edge of the strontium (Spectrum A) to the LIII  absorption edge of gold, results in a  narrow 
beam with energies with a higher probability of producing photoelectric than Spectrum B with the 
yttrium filter. However, filter’s density and thickness determines a greater or lesser fluence in each 















acquisition time. The competition of these factors determines that the configuration of Spectrum A 
achieves a lower LoD for gold fluorescent detection, with a similar dose within the error to that 
produced by Spectrum B configuration. 
 
 
Table 2. LoD obtained for each nanoparticle contrast among with dose values and resulting weighted LoD. 
Detection Spectrum ID LoD [mg/mL] 
 




















Spectrum C 0.095 (Au) 1.400 (Au) 0.385±0.009 
Spectrum D 0.286 (Ag) 1.936 (Ag) 0.260±0.008 
 
Apart from that, when analyzing the spectral region associated with the silver K-edge 
absorption energy, since both configurations of Spectrum A and B uses the same Sn filter, resulting 
spectra has the same a spectrally narrow beam centered at around 27.5 keV and with a slightly 
different relative fluence. 
The results obtained in the experiments carried out with a fixed LoD of 0.100 mg/mL are 
depicted in Table 3. Comparing dose values required for simultaneous detection of both nanoparticle 
agents with dose values of the independent measurements of each agent, it was possible to reach 
sensitivity detection levels 2.24 times lower for Spectrum A and 2.36 times lower for Spectrum B. The 
configuration of Spectrum B achieves the same LoD with a mean dose value smaller but 
undistinguished within the uncertainty than the one btained with Spectrum A. Although detection 
times are 2.48 times higher for Spectrum A and 2.22 times higher for Spectrum B compared to single 
element fluorescent detection, there are still reason ble times for in vivo applications. 
 
Table 3. Time and dose  required to obtain a LoD of 0.100 mg/mL with the optimized configurations of 
filters for simultaneously GNPs and AgNPs fluorescent detection, among with single GNPs and AgNPs 
fluorescent. 
Detection Spectrum ID Time [s] Dose [mGy] 
Simultaneous 
Spectrum A 681 1.02±0.03 
Spectrum B 608 0.97±0.03 
Single 
Spectrum C   28 0.16±0.01 
Spectrum D 246 2.13±0.05 
















Measured fluorescence signal intensity for different anoparticles contrast agent 
concentrations are depicted in Fig. 4 for Spectrum A and in Fig. 5 for Spectrum B, where each tumor 
phantom was constituted by both silver and gold nanop rticles. What is more, obtained results for 
individual element XRF detection are depicted in Fig. 6. Each curve has an inset graphic for the lower 
concentrations and the resulting detection limit is marked as a red-color area, determined by the 
intersection of the weighted linear least-squares fit and the value produced by 1.96σ of the blank 
sample. 
For simultaneous detection using Spectrum A, obtained LoD are 0.043 mg/mL for gold and 
0.019 mg/mL for silver. For simultaneous detection using Spectrum B, obtained LoD are 0.044 mg/mL 
for gold and 0.029 mg/mL for silver. Furthermore, gold XRF single detection reaches a LoD of 0.058 
mg/mL and silver XRF single detection 0.124 mg/mL. Even though only one filter was used for each 
element XRF single detection, higher dose values ar involved, therefore reducing acquisition time in 
order to preserve the 0.25 mGy accumulated dose during spectra acquisition.  
 
 
Fig 4. Calibration curve of gold L alpha XRF signal (left) and silver K alpha XRF signal (right) versus the NPs 
concentration of the tumor phantom for Spectrum A (Sr and Sn filters).  
 
 
Fig 5. Calibration curve of gold L alpha XRF signal (left) and silver K alpha XRF signal (right) versus the NPs 
















Fig 6. Calibration curve of gold L alpha XRF signal (left) and silver K alpha XRF signal (right) versus the NPs 
concentration of the tumor phantom for single element detection using Spectrum C for gold and Spectrum D for 
silver. 
 
Reported LoD for simultaneous gold and silver XRF detection were obtained using acquisition 
times to deliver a 0.250 mGy radiation dose to the tumor, value 40 times less than the 10 mGy value 
typically recommended for in vivo human X-ray analysis (Wielopolski, 1999), therefor the developed 
technique is in accordance with the “As Low As Reason bly Possible” (ALARA) principle. Because 
the present work is one of the first to perform a ch racterization of an optimized EDXRF system for 
simultaneous XRF detection of gold and silver nanoprticles agents, it has not been reported detection 
limit values so far that allow a comparison with the obtained results. In the case of single detection of 
gold XRF, previous work has reported a detection limit of 0.010 mg/mL for Au with benchtop X-ray 
devices (Ricketts et al., 2013), although using longer acquisition times and the dose administered by 





High sensitivity and low administered radiation dose was achieved by using combinations of 
absorption filters of different composition and thickness at the output of the X-ray beam to obtained 
two spectrally narrow beams that efficiently excite th  gold  LIII -edge and silver K-edge, respectively. 
The limit of detection achieved with these configurations was more than two times lower for both 
tested configurations when compared to the individual detection of the agents studied, mainly due to 
the shorter acquisition times used for single gold or silver fluorescent detection.  
To the best of author’s knowledge, it was possible to configure for the first time an X-ray 
fluorescence system that would allow the simultaneously in vivo detection and quantification of gold 
and silver nanoparticle agents, that may have certain characteristics necessary for future clinical in 















EDXRF system for the detection of the studied agents, close to the expected values of the 
concentrations found in vivo in the tumor. In addition, due to the application of ionizing radiation in 
humans, optimizations were made to reduce applied radiation dose, achieving values 40 times less 
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Caption to figure 1:  
EDXRF experimental setup for simultaneous gold and silver nanoparticles fluorescence detection 


























Caption to figure 2: 
 












































Caption to Figure 3: 
 
A) Optimized spectra obtained by combining different filters: Spectrum A (blue line) obtained using 212 µm Sr 
with 94.5 µm Sn filters and Spectrum B (black line) obtained using 130.2 µm Y with 94.5 µm Sn. B) Single 
element XRF detection: Spectrum C obtained with 130.2 µm Y filter (red line) and Spectrum D obtained with 

























































Caption to Figure 4: 
 
Calibration curve of gold L alpha XRF signal (left) and silver K alpha XRF signal (right) versus the NPs 























































Caption to Figure 5: 
 
Calibration curve of gold L alpha XRF signal (left) and silver K alpha XRF signal (right) versus the NPs 













































Caption to Figure 6: 
 
Calibration curve of gold L alpha XRF signal (left) and silver K alpha XRF signal (right) versus the NPs 


















• Optimized XRF simultaneous detection of Au and Ag 
nanoparticles in water-like phantoms. 
• Simultaneous detection can be suitably optimized by 
incident spectrum configuration.  
• Potentiality of simultaneous high Z agents’ detection for 
theranostics.  
